Blood drive held in memory of baby boy who died from pediatric cancer

Juno died at just three months old from a rare and aggressive pediatric cancer, prompting his family and supporters to take ...
Becker's Hospital Review

FDA stops Juno’s cancer drug trials after 3 patients die

The Food and Drug Administration halted Juno Therapeutics’ clinical trial for an experimental cancer drug following the death of three patients, according to Reuters. JCAR015 is a chimeric antigen ...
The Business Journals

Juno's delayed market launch of cancer drug opens window for competitor

Setback opens the window for competitor Kite Pharma Inc. Seattle-based Juno Therapeutics reaffirmed yesterday in a new SEC filing that Federal Drug Administration approval of its drug will not happen ...
Becker's Hospital Review

FDA removes clinical hold on Juno’s cancer drug study

The Food and Drug Administration has removed a clinical hold it placed on Juno’s mid-stage cancer drug trial after three patients died, according to Reuters. The FDA halted the study for JCAR015 last ...
Reuters

REFILE-Celgene, Juno collaborate to develop cancer therapies

June 29 (Reuters) - Celgene Corp and Juno Therapeutics Inc said they signed a deal to develop and commercialize immunotherapies for the treatment of cancer and autoimmune diseases. Juno will receive ...
Reuters

Cancer drug developer Juno Therapeutics rises 64.5 pct in debut

Dec 19 (Reuters) - Shares of Juno Therapeutics Inc, a biopharmaceutical company working on cancer treatments, rose as much as 64.5 percent in their market debut, valuing the company at about $3 ...